Remed Co.,Ltd. (KOSDAQ:302550)
South Korea · Delayed Price · Currency is KRW 2,625.00
+120.00 (4.79%)
At close: Nov 13, 2026
Remed Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 77,434 | 94,885 | 110,297 | 99,727 | 75,676 | 162,688 | |
Market Cap Growth | -21.10% | -13.97% | 10.60% | 31.78% | -53.48% | -18.29% |
Enterprise Value | 74,451 | 86,055 | 109,398 | 103,407 | 65,948 | 142,621 |
Last Close Price | 2625.00 | 3070.00 | 3600.00 | 3255.00 | 2470.00 | 5310.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 55.23 | 180.32 | 15.38 | 125.10 | 18.92 | 216.25 |
PS Ratio | 2.86 | 3.87 | 4.32 | 5.38 | 3.54 | 8.06 |
PB Ratio | 2.02 | 2.26 | 2.59 | 3.24 | 2.52 | 6.23 |
P/TBV Ratio | 2.11 | 2.46 | 2.86 | 3.26 | 2.55 | 6.32 |
P/FCF Ratio | 54.63 | 62.04 | 167.48 | 36.82 | 289.83 | - |
P/OCF Ratio | 28.55 | 39.60 | 88.63 | 28.50 | 14.52 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.75 | 3.51 | 4.28 | 5.58 | 3.09 | 7.06 |
EV/EBITDA Ratio | 21.99 | 40.17 | 45.60 | - | 27.29 | 84.70 |
EV/EBIT Ratio | 38.12 | 118.56 | 97.57 | - | 39.70 | 126.98 |
EV/FCF Ratio | 52.53 | 56.26 | 166.11 | 38.18 | 252.58 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.15 | 0.13 | 0.18 | 0.60 | 0.65 | 0.75 |
Debt / EBITDA Ratio | 1.75 | 2.54 | 3.24 | - | 8.09 | 11.66 |
Debt / FCF Ratio | 4.18 | 3.55 | 11.81 | 6.76 | 74.90 | - |
Net Debt / Equity Ratio | -0.12 | -0.18 | -0.07 | 0.39 | -0.37 | -0.64 |
Net Debt / EBITDA Ratio | -1.36 | -3.55 | -1.21 | -6.33 | -4.58 | -9.97 |
Net Debt / FCF Ratio | -3.26 | -4.97 | -4.41 | 4.45 | -42.40 | 2.26 |
Asset Turnover | 0.50 | 0.43 | 0.45 | 0.28 | 0.28 | 0.27 |
Inventory Turnover | 1.60 | 1.55 | 1.87 | 1.73 | 2.07 | 2.50 |
Quick Ratio | 2.18 | 2.91 | 2.80 | 0.64 | 0.82 | 7.80 |
Current Ratio | 3.09 | 4.03 | 4.23 | 1.02 | 0.97 | 8.71 |
Return on Equity (ROE) | 3.02% | -0.08% | 20.13% | 1.05% | 14.09% | 2.96% |
Return on Assets (ROA) | 2.25% | 0.80% | 1.23% | -2.68% | 1.34% | 0.93% |
Return on Invested Capital (ROIC) | 5.04% | 1.96% | 2.49% | -3.02% | 10.19% | 15.87% |
Return on Capital Employed (ROCE) | 4.30% | 1.50% | 2.10% | -7.50% | 4.80% | 1.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 1.81% | 0.56% | 6.50% | 0.80% | 5.29% | 0.46% |
FCF Yield | 1.83% | 1.61% | 0.60% | 2.72% | 0.34% | -4.57% |
Buyback Yield / Dilution | 6.64% | 7.99% | -9.33% | - | -0.35% | -1.84% |